Ghent University Academic Bibliography

Your filters: cql: author="Denys, Hannelore" or (type any "bookEditor issueEditor" and editor="Denys, Hannelore")

Add to list
- Journal Article
- A1
- open access
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer : a multicenter, single-arm phase 2a study

Peter Hillemanns, Michal Zikan, Frédéric Forget, Hannelore Denys (UGent) , Jean-Francois Baurain, Lukas Rob, Linn Woelber, Pawel Blecharz, Mariusz Bidzinski, Josef Chovanec, et al.

(2025) JOURNAL FOR IMMUNOTHERAPY OF CANCER. 13(1).
Add to list
- Journal Article
- A1
- open access
Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer

Whitney S Graybill, Ignace Vergote, Bhavana Pothuri, Maarit Anttila, David M O'Malley, Domenica Lorusso, Ashley F Haggerty, Michel Fabbro, John K Chan, Florian Heitz, et al.

(2025) JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH. 14(1).
Add to list
- Journal Article
- A1
- open access
Tumor Treating Fields therapy in platinum-resistant ovarian cancer : results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study

Ignace Vergote, Larry J. Copeland, Toon Van Gorp, Annouschka Laenen, Giovanni Scambia, Premal H. Thaker, David Cibula, Nicoletta Colombo, Jayanthi Lea, Antonio Gonzalez-Martin, et al.

(2025) EUROPEAN JOURNAL OF CANCER. 219.
Add to list
- Journal Article
Management of severe capecitabine-induced corneal toxicity

Mathieu Heyvaert, Hannelore Denys (UGent) , Jo Van Dorpe (UGent) and Dimitri Roels (UGent)

(2024) American Journal of Ophthalmology Case Reports. 36.
Add to list
- Journal Article
- A1
- open access
Overall survival and exploratory biomarker analyses of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus chemotherapy in HR+, HER2+ metastatic breast cancer patients

Sara M. Tolaney, Shom Goel, Jorge Nadal, Hannelore Denys (UGent) , Manuel R. Borrego, Lacey M. Litchfield, Jiangang Liu, Adams K. Appiah, Yanyun Chen and Fabrice André

(2024) CLINICAL CANCER RESEARCH. 30(1). p.39-49
Add to list
- Journal Article
- A1
- open access
Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study

Charlotte Fieuws (UGent) , Joni Van der Meulen (UGent) , Kristiaan Proesmans (UGent) , Emiel De Jaeghere (UGent) , Siebe Loontiens (UGent) , Jo Van Dorpe (UGent) , Philippe Tummers (UGent) , Hannelore Denys (UGent) , Koen Van de Vijver (UGent) and Kathleen Claes (UGent)

(2024) NPJ PRECISION ONCOLOGY. 8(1).
Add to list
- Journal Article
- A1
- open access
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer : ALEPRO trial

Tine Ottenbourgs, Toon van Gorp, Frédéric Kridelka, Thaïs Baert, Hannelore Denys (UGent) , Frédéric Selle, Inge Baas (UGent) , Anne-Sophie Van Rompuy, Diether Lambrechts and Els Van Nieuwenhuysen

(2024) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 34(4). p.627-630
Add to list
- Journal Article
- A1
- open access
Cancer‐associated fibroblasts mediate resistance to neoadjuvant therapy in breast cancer

Zihan Xia (UGent) , Stephanie Vermeulen (UGent) , Ujjwal Suwal, Pekka Rappu, Jyrki Heino, Felix De Vuyst (UGent) , Sandor Dedeyne (UGent) , An Hendrix (UGent) , Hannelore Denys (UGent) and Olivier De Wever (UGent)

(2024) CLINICAL AND TRANSLATIONAL MEDICINE. 14(7).
Add to list
- Journal Article
- A1
- open access
Zebrafish avatars : toward functional precision medicine in low-grade serous ovarian cancer

Charlotte Fieuws (UGent) , Jan Willem Bek (UGent) , Bram Parton (UGent) , Elyne De Neef (UGent) , Olivier De Wever (UGent) , Milena Hoorne (UGent) , Marta F. Estrada, Jo Van Dorpe (UGent) , Hannelore Denys (UGent) , Koen Van de Vijver (UGent) , et al.

(2024) CANCERS. 16(10).
Add to list
- Journal Article
- A1
- open access
Exclusion of non-involved uterus from the target volume (EXIT-trial) : an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques followed by completion surgery

Axel Van Damme, Philippe Tummers (UGent) , Pieter De Visschere (UGent) , Jo Van Dorpe (UGent) , Koen Van de Vijver (UGent) , Tom Vercauteren (UGent) , Werner De Gersem (UGent) , Hannelore Denys (UGent) , Eline Naert (UGent) , Amin Makar (UGent) , et al.

(2024) CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 47.

Academic Bibliography

Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer : a multicenter, single-arm phase 2a study

Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer

Tumor Treating Fields therapy in platinum-resistant ovarian cancer : results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study

Management of severe capecitabine-induced corneal toxicity

Overall survival and exploratory biomarker analyses of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus chemotherapy in HR+, HER2+ metastatic breast cancer patients

Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study

A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer : ALEPRO trial

Cancer‐associated fibroblasts mediate resistance to neoadjuvant therapy in breast cancer

Zebrafish avatars : toward functional precision medicine in low-grade serous ovarian cancer

Exclusion of non-involved uterus from the target volume (EXIT-trial) : an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques followed by completion surgery

Contents

Support

Contact